Who invested in Gladius Pharmaceuticals?
Gladius Pharmaceuticals's investors include SR One, Fonds de solidarite Ftq, Lumira Ventures and GlaxoSmithKline.
Canada · Venture startup
Funding summaryUpdated 26 Oct 2026
$3.3Mraised across 2 rounds since 2015, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $3.0M sold, first sale Nov 2018
From a historical funding recordSEC filing: $728K sold, first sale Jun 2015
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Gladius Pharmaceuticals's investors include SR One, Fonds de solidarite Ftq, Lumira Ventures and GlaxoSmithKline.
Gladius Pharmaceuticals has raised $3.3M across 2 rounds since 2015. One round did not disclose an amount, so the total is a floor.
Gladius Pharmaceuticals's most recent round was a Venture in Nov 2018.
Gladius Pharmaceuticals's largest round on record is $3.3M (Series A), in Jun 2015.
Gladius Pharmaceuticals's first round on record, in Jun 2015, was backed by SR One, Fonds de solidarite Ftq and Lumira Ventures and 1 others.
Gladius Pharmaceuticals's latest named round is a Venture, in Nov 2018.
Gladius Pharmaceuticals is based in Canada.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.